Rebeca Martinez-Hernandez
Overview
Explore the profile of Rebeca Martinez-Hernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sampedro-Nunez M, Bouthelier A, Serrano-Somavilla A, Martinez-Hernandez R, Adrados M, Martin-Perez E, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33066332
Cancer cells develop mechanisms that increase nutrient uptake, including key nutrient carriers, such as amino acid transporter 1 (LAT-1) and glucose transporter 1 (GLUT-1), regulated by the oxygen-sensing Von Hippel...
12.
Ortega-Rodriguez A, Martinez-Hernandez R, Monsivais-Urenda A, Serrano-Somavilla A, Sanchez-Gutierrez R, Gonzalez-Amaro R, et al.
J Clin Endocrinol Metab
. 2020 Aug;
105(11).
PMID: 32823277
Context: Natural killer (NK) cells have an important role in innate immunity and in the regulation of immune response. The role of NK cells expressing the programmed cell death protein-1...
13.
Martinez-Hernandez R, de la Fuente H, Lamana A, Sampedro-Nunez M, Ramos-Levi A, Serrano-Somavilla A, et al.
J Autoimmun
. 2020 May;
111:102472.
PMID: 32381457
Immune-mediated inflammatory disorders (IMID) are a group of diseases that present inflammation as a major pathogenic mechanism. They affect 15% of the population and pose a heavy socio-economic burden. Despite...
14.
Martinez-Hernandez R, Serrano-Somavilla A, Ramos-Levi A, Sampedro-Nunez M, Lens-Pardo A, de Nova J, et al.
EBioMedicine
. 2019 Nov;
50:329-342.
PMID: 31735554
Background: The mechanisms underlying autoimmune thyroid disease (AITD) remain elusive. Identification of such mechanisms would reveal novel and/or better therapeutic targets. Here, we use integrated analysis of miRNAs and mRNAs...
15.
Vitales-Noyola M, Serrano-Somavilla A, Martinez-Hernandez R, Sampedro-Nunez M, Ramos-Levi A, Gonzalez-Amaro R, et al.
J Clin Endocrinol Metab
. 2019 Oct;
105(1).
PMID: 31665332
No abstract available.
16.
Sampedro-Nunez M, Serrano-Somavilla A, Adrados M, Cameselle-Teijeiro J, Blanco-Carrera C, Cabezas-Agricola J, et al.
Sci Rep
. 2018 Dec;
8(1):17812.
PMID: 30546030
The immune checkpoint based therapy targeting the programmed death-1 (PD-1) receptor and its PD-L1 ligand has recently been approved for the therapy of different malignant conditions, but not yet for...
17.
Vitales-Noyola M, Serrano-Somavilla A, Martinez-Hernandez R, Sampedro-Nunez M, Ramos-Levi A, Gonzalez-Amaro R, et al.
J Clin Endocrinol Metab
. 2018 Jul;
103(9):3359-3367.
PMID: 29982465
Context: T regulatory type 1 (Tr1) cells are a subpopulation of T lymphocytes (CD4+CD49+LAG-3+IL-10+) that exert a considerable immunosuppressive effect. However, their possible role in autoimmune thyroid disease (AITD) has...
18.
Martinez-Hernandez R, Sampedro-Nunez M, Serrano-Somavilla A, Ramos-Levi A, de la Fuente H, Trivino J, et al.
J Clin Endocrinol Metab
. 2018 Jan;
103(3):1139-1150.
PMID: 29325052
Context: Circulating microRNAs (miRNAs) are emerging as an interesting research area because of their potential role as novel biomarkers and therapeutic targets. Their involvement in autoimmune thyroid diseases (AITDs) has...
19.
Vitales-Noyola M, Ramos-Levi A, Martinez-Hernandez R, Serrano-Somavilla A, Sampedro-Nunez M, Gonzalez-Amaro R, et al.
Endocrine
. 2017 Jul;
57(3):409-417.
PMID: 28669056
Purpose: To study the levels of pathogenic and non-pathogenic Th17 and Th22 cells in autoimmune thyroid disorders patients. Although Th17 cells seem to play an important role in the pathogenesis...
20.
Vitales-Noyola M, Ramos-Levi A, Serrano-Somavilla A, Martinez-Hernandez R, Sampedro-Nunez M, Di Pasquale C, et al.
J Clin Endocrinol Metab
. 2016 Nov;
102(2):672-680.
PMID: 27854550
Context: Signaling lymphocytic activation molecule family 1 (SLAMF1) is a costimulatory receptor expressed by most immune cells. Its role in autoimmune thyroid disease (AITD) is not well known. Objective: To...